Charles River Laboratories will acquire Cognate BioServices in an $875 million cash deal that will significantly expand the company's capabilities in the high-growth cell and gene therapy sector.17 feb 2021
(ps Cognate BioServices was LP's previous CDMO. She didnt receive the stated $875 million, but it provides an indication of how much her second CDMO is worth.)
I responded to your post awhile back and your numbers were completely off.
No they were not my numbers were right on the mark. I didnt respond to your numbers because they were ridiculous, just as I proved that your claim today is again false.
You know Cognate went for $875M, right? Avid (formerly PPHM) currently has a $800M market cap. Sawston’s value is unknown thanks to a nebulous arrangement. Value should be set at about a 5X multiple so where is it?…
Or is the current NWBO $400M market cap really reflect Sawston with DCVAX having little value?